Digital Pharma news
26.1K views | +0 today
Follow
Digital Pharma news
Actualité de la pharma et du digital
Curated by Rémy TESTON
Your new post is loading...
Your new post is loading...
Rescooped by Rémy TESTON from Pharma Hub
January 19, 2014 4:03 AM
Scoop.it!

Pharma Companies Working on Maximizing ROI on e-Detailing

Pharma Companies Working on Maximizing ROI on e-Detailing | Digital Pharma news | Scoop.it
Despite pharma’s best efforts to improve systems for calling on physicians, access to targets remains a problem across the industry.

Via Philippe Marchal
No comment yet.
Rescooped by Rémy TESTON from healthcare technology
January 12, 2014 3:38 PM
Scoop.it!

Drug Companies Could Use EHR Systems for Targeted Marketing

Drug Companies Could Use EHR Systems for Targeted Marketing | Digital Pharma news | Scoop.it

Pharmaceutical companies increasingly are using electronic health records to analyze patient data and market their products to consumers and physicians through advertisements and email campaigns.

 

Electronic health record systems could be used by pharmaceutical companies to market their products to physicians and consumers,Reuters reports.

 

Pharmaceutical companies historically have gathered patients' de-identified data from insurers, pharmacies and public records to improve their marketing strategies.

 

However, drug companies can collect and analyze data through EHR systems and use that information to reach out to consumers and doctors.

 


Via nrip
No comment yet.
Rescooped by Rémy TESTON from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
December 16, 2013 11:51 AM
Scoop.it!

Mobile Apps Will Transform All Business: And Pharma?

Mobile Apps Will Transform All Business: And Pharma? | Digital Pharma news | Scoop.it
Over the last 12 months I’ve surveyed over 700 companies, asking them if they have developed any mobile apps internally to help them with such things as supply chain management, logistics, purchasing (Mobile Apps Will Transform All Business...

Via eMedToday
No comment yet.
Rescooped by Rémy TESTON from Digital Health
December 2, 2013 8:45 AM
Scoop.it!

Discussing digital talent in Pharma with Alex Clarke | DigitallySick

Discussing digital talent in Pharma with Alex Clarke | DigitallySick | Digital Pharma news | Scoop.it

The Digitally Sick team discuss the question: Does pharma need an injection of external talent to speed up the adoption of digital technologies and sharpen their digital strategy?

 

The pod chats with guest Alex Clarke from Sanofi about what this talent would be, what they would do and how this would improve pharma digital.

 

We also discuss the pharma agency landscape and ask if this needs a reboot.


Via Alex Butler
No comment yet.
Rescooped by Rémy TESTON from New pharma
November 9, 2013 7:00 AM
Scoop.it!

Innovative care partnerships .. new engagements for collaboration between healt care and health industry

Innovative care partnerships .. new engagements for collaboration between healt care and health industry | Digital Pharma news | Scoop.it

As the health service grapples with the need to provide quality care while containing spiralling patient care costs (something all stakeholders will need to do for decades to come), the ability to manage care in a holistic, safe and cost effective way is a priority for commissioners. 

Choosing the best healthcare partner to deliver these often complex and detailed healthcare requirements is high on the agenda for many commissioners and with the recent changes to NHS commissioning and the publication of the Homecare Medicines Review guidelines, this task has become even more important to get right first time round.

So what can you do to ensure the right partnerships are formed that best meet your individual service objective needs?

First of all, the healthcare partner should offer a broad and integrated range of services such as medicines distribution/logistics, clinical homecare, medicines support, dispensing services, medicine preparation and clinical trial support. Not only does provision of these cohesive services avoid the need for other external partners and contracts, but it also creates the flexibility to add-on future services as end-to-end patient healthcare needs develop and expand. 

In addition, this fully integrated approach has a greater potential to lead to service efficiencies, flexible service delivery and improved patient care. ..

The healthcare partner must help patients make better use of the medicines and therapies they are prescribed and by doing so, the NHS can be supported to deliver the demands of the Government's QIPP (Quality, Innovation, Productivity and Prevention) agenda ..

..

Most importantly, a partner should be able to demonstrate a strong track record of patient-centric care that supports patients throughout their care journey...

An aspect which is perhaps given less weight is the existence of shared values and complementary multi-disciplinary expertise between stakeholder organisations. In my opinion, evidence of this is critical to engender mutual trust and respect between both organisations, as no doubt the ability for co-operative working will be tested under the current challenging and changing healthcare environment.

Ultimately, the true measure of success will be the strength of the relationship between the healthcare provider and partner as they work together in the pursuit of mutual goals to deliver the best possible care for their patients.


Via rob halkes
rob halkes's curator insight, November 8, 2013 5:40 AM

Great insight into the next age of health provision!

Given the current economic and health budgets' condtions, but also raising demands on health quality, will bring different parties in care provision together. When they can find ways to integrate their business models, which is one of the hardest issues to complete, new cost savings might render sustainable return to the partners in care.

Health industry and health care parties have a challenge ahead.

 

Want to know more? Just connet with me and find out about the various ways, I can inform you about my practical experiences to this.
rob.halkes@healthbusinessconsult.com

rob halkes's curator insight, November 8, 2013 5:48 AM

Great insight into the next age of health provision!

Given the current economic and health budgets' condtions, but also raising demands on health quality, will bring different parties in care provision together. When they can find ways to integrate their business models, which is one of the hardest issues to complete, new cost savings might render sustainable return to the partners in care.

Health industry and health care parties have a challenge ahead.

 

Want to know more? Just connet with me and find out about the various ways, I can inform you about my practical experiences to this.
rob.halkes@healthbusinessconsult.com

Scooped by Rémy TESTON
November 4, 2013 7:30 AM
Scoop.it!

Pharmaceutical companies 'should establish Social Media policy'

Pharmaceutical companies 'should establish Social Media policy' | Digital Pharma news | Scoop.it

Pharmaceutical companies should establish a corporate social media policy, attorney John Manthei, with Latham & Watkins LLP in Washington, said Sept. 17.

 

Speaking during a session on drug product compliance at the Food and Drug Law Institute's Advertising & Promotion Conference, Manthei said the Food and Drug Administration is “incredibly” advanced at using social media, but it hasn't yet said how it will regulate others when it comes to social media.

Manthei said the FDA is required by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA) to issue specific guidance on social media by July 9, 2014. However, he said FDA's message in warning letters has been that “current standards apply” when it comes to social media.

Social media is “interactive and the formats are constantly evolving,” Manthei said.

 

Manthei said companies should establish a “clear corporate social media policy and provide adequate training to employees.”

Manthei also said that “if you plan to allow third-party content on company-hosted media, ensure [that] you maintain control to maintain compliance.” Specifically, he said companies should have a clear “terms of use” to alert users that content will be reviewed and may be deleted.

Additionally, Manthei said that companies should ensure that their internal and promotional labeling review program is “attuned to developing issues in the media space.”

Felix Jackson's curator insight, September 20, 2013 5:21 AM

Specific considerations for social media:

• “clear corporate social media policy and provide adequate training to employees.”

• “if you plan to allow third-party content on company-hosted media, ensure [that] you maintain control to maintain compliance.”

• Have a clear “terms of use” to alert users that content will be reviewed and may be deleted.

 

But the main considerations remain the big ones:

• partner with marketing team members to ensure risk presentations get equal time and attention in promotional materials during the drafting stage (including labeling);

• lean on medical reviewers to understand study designs and the limitations for supporting data;

• not overlook investigational product materials and websites;

• ensure product-related press releases undergo multidisciplinary review; and

• inventory claims supported by composite score data for overstatement of efficacy.

Scooped by Rémy TESTON
October 31, 2013 3:02 AM
Scoop.it!

Pharmaceutical marketing in the postmarketing age

Pharmaceutical marketing in the postmarketing age | Digital Pharma news | Scoop.it

Few publications that consider the pharmaceutical industry’s participation in digital environments neglect to mention ‘marketing’ in some capacity.

 

We genuflect to ‘marketing’ so freely, deploy it in our discourse with such profligate frequency, and elevate the study of its operations to such a degree that a casual observer could be led to imagine that the concept of ‘marketing’ was in some way intrinsic to every facet of a pharmaceutical company’s success.

 

‘No marketing, no pharmaceutical company,’ one might conclude, as if no prescription would ever be written, nor any course of treatment embarked upon without it.

 

However, the premise upon which this post is based is that the exact opposite is in fact true, and that the continued pursuit of ‘marketing’ by the pharmaceutical industry as it is currently practiced has the potential to irreparably damage the industry’s reputation, further undermine health consumer trust in its operations, impact upon its profitability, and undermine the viability of its future operations.

 

No comment yet.
Scooped by Rémy TESTON
October 7, 2013 7:24 AM
Scoop.it!

Votre dossier médical bientôt consultable sur smartphone

Votre dossier médical bientôt consultable  sur smartphone | Digital Pharma news | Scoop.it
Votre dossier médical bientôt consultable par un médecin sur tablette ou sur smartphone ! Un procédé nouveau que vient de mettre au point le laboratoire "Orange Labs" de Caen en Normandie.
No comment yet.
Rescooped by Rémy TESTON from Digital Health
October 6, 2013 10:30 AM
Scoop.it!

How Can Pharma Be Inspired by other industries? | DigitallySick

How Can Pharma Be Inspired by other industries? | DigitallySick | Digital Pharma news | Scoop.it

Via Alex Butler
Alex Butler's curator insight, October 4, 2013 11:46 AM

How can healthcare and pharma be inspired by other industries? I they could be who would they take inspiration from to drive innovation? Could other industries be inspired by healthcare?

 

The pod are joined by special guest Angela Dunn (@blogbrevity) who lends her considerable expertise to the topic, joining the usual team line-up

Scooped by Rémy TESTON
September 25, 2013 4:08 PM
Scoop.it!

Vente de médicaments sur Internet : attention aux falsifications, prévient l’ANSM MyPharma Editions | L'Info Industrie & Politique de Santé

Vente de médicaments sur Internet : attention aux falsifications, prévient l’ANSM MyPharma Editions | L'Info Industrie & Politique de Santé | Digital Pharma news | Scoop.it
L’ANSM relaie la campagne du Ministère des Affaires sociales et de la Santé sur la contrefaçon des médicaments et souhaite rappeler que l’achat de médicament sur Internet doit se faire dans ce circuit légal.
No comment yet.
Rescooped by Rémy TESTON from i-Pharma Digital
September 6, 2013 3:25 AM
Scoop.it!

2015 Pharma Rep Experience

A perspective on the big trends that are changing pharmaceutical sales and the new best practices and opportunities those trends inspire.

Via Nikos Papaioannou
No comment yet.
Scooped by Rémy TESTON
July 27, 2013 6:12 AM
Scoop.it!

Un robot d'imagerie médicale piloté par iPhone | Humanoides.fr ...

Un robot d'imagerie médicale piloté par iPhone | Humanoides.fr ... | Digital Pharma news | Scoop.it
Il y a une application pour tout. Un groupe de chercheurs japonais vient une fois encore de le prouver avec ce robot d'imagerie médicale piloté à partir d'un iPhone. Ce robot de santé, encore au stade de prototype, a été ...
No comment yet.
Rescooped by Rémy TESTON from Digital marketing pharma
July 23, 2013 3:31 AM
Scoop.it!

Can Pharma collaborate effectively online with the medical community? » gary monk 's blog

Can Pharma collaborate effectively online with the medical community? » gary monk 's blog | Digital Pharma news | Scoop.it

Actually Pharma often has a clear goal for why it wants to work with online communities, which is a good start.  The issue, perhaps unsurprisingly is that the goal is often self-serving.  Exciting for the Pharma company, less so for the HCPs.

 


Via Olivier Delannoy
No comment yet.
Scooped by Rémy TESTON
January 16, 2014 3:01 AM
Scoop.it!

90 supports d'informations online, proposés par la pharma

90 supports d'informations online, proposés par la pharma | Digital Pharma news | Scoop.it
En ce début d’année, il est encore temps de faire un bilan sur les réalisations digitales réalisées par l’industrie pharmaceutique depuis ces derniers mois. Pour avoir un aperçu des divers domaines...
No comment yet.
Rescooped by Rémy TESTON from i-Pharma Digital
December 21, 2013 6:57 AM
Scoop.it!

Pharma gets social: Top-10 pharma social media firsts in 2013

Pharma gets social: Top-10 pharma social media firsts in 2013 | Digital Pharma news | Scoop.it
Daniel Ghinn continues his series on the use of social media in the pharmaceutical industry by reviewing social media use in 2013 by pharma and sharing a list of his top-ten favourite pharma social media 'firsts' this year.

Via Nikos Papaioannou
COM SALUD's curator insight, December 17, 2013 3:37 AM

Aunque las restricciones en la comunicación con los pacientes no son las mismas en Estados Unidos que en Europa, se puede aprender mucho de la labor en redes sociales que muchos laboratorios realizan en otros países. No tratan de "vender" las ventajas de un medicamento sino de involucrar a los pacientes en aspectos como la prevención y el autocuidado de su salud, lo que éstos agradecen en las redes.

Rescooped by Rémy TESTON from Content Marketing and content sourcing
December 8, 2013 8:06 AM
Scoop.it!

Digital Media is Now the Preferred Source by Physicians for Accessing Information from Pharmaceutical Companies Over Traditional In-Person...

New study shows role of pharmaceutical representatives must evolve into multi-channel information resources for physicians or risk losing influence as

Via Olivier Delannoy
eMedToday's curator insight, December 7, 2013 1:58 AM

-Capgemini Consulting, the global strategy and transformation consulting arm of the Capgemini Group, in collaboration with leading physician relationship management provider Quantia, today announced findings from a new joint study that shows pharmaceutical companies’ shrinking access to physicians through traditional sales representatives is putting their in-office engagement strategy in flux. The study of nearly 3,000 primary care physicians and specialists from the QuantiaMD U.S. community, found that 67 percent of physicians now rate digital media as their preferred source for accessing information, compared to just 20 percent who prefer pharmaceutical representatives. This shift is compelling pharmaceutical companies to place more emphasis on their digital strategies to maintain their role as a trusted information resource.

Estelle Ayer's curator insight, December 9, 2013 3:26 AM

New role of pharmaceutical reps, evolution of working models thanks to digital

Rescooped by Rémy TESTON from Pharma Marketing
December 2, 2013 8:40 AM
Scoop.it!

Pharma Digital Trends 2014: Content Curation

Pharma Digital Trends 2014: Content Curation | Digital Pharma news | Scoop.it
Continuing our blog series discussing where we expect pharma marketers to be with their digital marketing strategies in 2014, we continue this week w

Via COUCH Medcomms
No comment yet.
Scooped by Rémy TESTON
November 5, 2013 5:26 AM
Scoop.it!

Google+ est désormais le numéro 2 des réseaux sociaux

Google+ est désormais le numéro 2 des réseaux sociaux | Digital Pharma news | Scoop.it

L'évocation de réseaux sociaux fait immédiatement penser à Facebook ou Twitter pourtant Google+ accroit son audience de mois en mois au point d'être désormais le numéro 2.

No comment yet.
Scooped by Rémy TESTON
November 4, 2013 3:32 AM
Scoop.it!

L’industrie pharmaceutique à l’heure du marketing digital | Le Cercle Les Echos

L’industrie pharmaceutique à l’heure du marketing digital | Le Cercle Les Echos | Digital Pharma news | Scoop.it
No comment yet.
Scooped by Rémy TESTON
October 17, 2013 10:05 AM
Scoop.it!

Wikipedia is a pharma marketing issue

Wikipedia is a pharma marketing issue | Digital Pharma news | Scoop.it

In a previous post on this blog, Catch on to content marketing, I wrote that Pharma’s content-marketing opportunity is to make sure that when a doctor or a patient goes searching for health information that the right content is there waiting for them. In the same post I quoted Dr Candice O’Sullivan of Australia’s Wellmark agency describing Pharma as “an industry well used to the rigours of consistently producing high-quality content.”

 

And yet, millions of patients and doctors still go to Wikipedia every month for the answers to their questions. I think that’s what’s known on the internet as a #Fail.

No comment yet.
Scooped by Rémy TESTON
October 7, 2013 7:23 AM
Scoop.it!

Pharma social media: come on in

Pharma social media: come on in | Digital Pharma news | Scoop.it

There’s a database that tracks pharma conflicts with the FDA about social media, and Mark Senak runs it.

No comment yet.
Rescooped by Rémy TESTON from Digital marketing pharma
September 27, 2013 7:28 AM
Scoop.it!

Being a Community Manager in Pharma @ ePatCon12 - PharmFresh.TV

Being a Community Manager in Pharma @ ePatCon12 - PharmFresh.TV | Digital Pharma news | Scoop.it

What are the responsibilities of a community manager (in pharma)?
How do you connect with the diabetes communities and become a legitimate participant in the conversation?
How do you demonstrate the value of your engagement with the community back to the diabetes franchise and your organization overall?....


Via Olivier Delannoy
No comment yet.
Scooped by Rémy TESTON
September 25, 2013 1:48 AM
Scoop.it!

Pfizer begins using ‘digital’ reps | Pharmafile

Pfizer begins using ‘digital’ reps | Pharmafile | Digital Pharma news | Scoop.it
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.
No comment yet.
Rescooped by Rémy TESTON from Pharma Hub
August 11, 2013 4:15 AM
Scoop.it!

3 ideas for pharma companies to become bigger players in mobile health

3 ideas for pharma companies to become bigger players in mobile health | Digital Pharma news | Scoop.it
One research firm thinks that pharma companies' app have been too niche, not designed with best practices in mind and not integrated with companies' core business.

Via Philippe Marchal
No comment yet.
Scooped by Rémy TESTON
July 27, 2013 6:11 AM
Scoop.it!

eDetailing: The future for pharma communication?

eDetailing: The future for pharma communication? | Digital Pharma news | Scoop.it

Dinesh Chindarkar, Co-founder, MediaMedic Communications elucidates about eDetailing – where technology and graphics, married with rich content, come to the rescue of mundane communication. Detailing has always been the backbone of doctors’ communication with the pharma industry for over the last three to four decades. This print tool, though has undergone quality improvements in terms of its content, visual appeal, some added gimmicks etc; all these have been value-adds within the box. Nothing has challenged it so far.

With the advent of technology, video content, graphics, motion and interactivity, and newer digital tools are challenging this visual aid and redefining communication. This version of detailing adds an ‘e’ of electronic to it, making it completely different from the current mode of communication. A different form of eDetailing is one where communication is sent to doctors on the PC without a personal interaction. But we are talking of eDetailing in the context where the electronic detailing aid is used by the sales rep in person-to-person call.

The objective of having a rich, content – driven conversation with the doctor, so as to discuss about newer medical advances, sharing updated information and help him make the right decision for prescription can be achieved using eDetailing. All this can be done weaving the brand within the conversation rather than the brand dominating the communication.

 

 

 

eMedToday's curator insight, July 26, 2013 8:12 PM

 

This does reflect the changing trend.

However, problem is getting in front of the doctor.

Self directed e detialing it the future